Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) has been assigned a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued a report on the stock in […]
Analysts Weekly Ratings Changes for Actinium Pharmaceuticals (ATNM) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Stock Rating Reaffirmed by HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright restated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $50.00 price objective on the biotechnology company’s stock. Other analysts have also issued research reports about the company. B. Riley decreased their price […]
HC Wainwright reissued their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $50.00 price objective on the biotechnology company’s stock. ATNM has been the subject of a number of other research reports. StockNews.com lowered Actinium Pharmaceuticals from a […]